These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33766006)

  • 1. Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.
    Wilson EK; Wagner LD; Palanee-Phillips T; Roberts ST; Tolley EE; Mathebula F; Pascoe L; Lanham M; Wilcher R; Montgomery ET;
    BMC Womens Health; 2021 Mar; 21(1):126. PubMed ID: 33766006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study.
    Montgomery ET; Roberts ST; Reddy K; Tolley E; Hartmann M; Wilson E; Mathebula F; Wagner LD; Zissette S; Lanham M; Wilcher R; Baeten JM; Palanee-Phillips T
    AIDS Behav; 2022 Mar; 26(3):752-763. PubMed ID: 34546473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring Effects of Counseling to Increase Pre-Exposure Prophylaxis Adherence and Partner Support in South Africa Using the Healthy Relationship Assessment Tool.
    Zissette S; Tolley EE; Martinez A; Roberts ST; Palanee-Phillips T; Montgomery ET
    Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M; Lanham M; Palanee-Phillips T; Mathebula F; Tolley EE; Peacock D; Pascoe L; Zissette S; Roberts ST; Wagner D; Wilson E; Ayub A; Wilcher R; Montgomery ET;
    AIDS Educ Prev; 2019 Oct; 31(5):433-451. PubMed ID: 31550193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial.
    Hartmann M; Triplett N; Roberts ST; Lanham M; Reddy K; Tenza S; Mayisela N; Mbewe D; Maboa O; Mampuru L; Tolley EE; Palanee-Phillips T; Montgomery ET
    BMC Womens Health; 2023 Aug; 23(1):440. PubMed ID: 37608373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study.
    Tolley EE; Martinez A; Zissette S; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2021; 16(12):e0261526. PubMed ID: 34972141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use.
    Tolley EE; Zissette S; Martinez A; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2020; 15(12):e0242881. PubMed ID: 33351805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa.
    Montgomery ET; Roberts ST; Reddy K; Tolley EE; Hartmann M; Mathebula F; Wagner LD; Lanham M; Wilcher R; Browne EN; Baeten JM; Palanee-Phillips T
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):425-433. PubMed ID: 35416797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of universal screening for intimate partner violence in voluntary HIV testing and counseling services in South Africa and service implications.
    Christofides N; Jewkes R
    AIDS Care; 2010 Mar; 22(3):279-85. PubMed ID: 20390507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa.
    Colombini M; Scorgie F; Stangl A; Harvey S; Ramskin L; Khoza N; Mashauri E; Baron D; Lees S; Kapiga S; Watts C; Delany-Moretlwe S;
    BMC Public Health; 2021 Mar; 21(1):433. PubMed ID: 33658000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women: An Analysis of Data from the Charisma Study.
    Triplett NS; Roberts ST; Hartmann M; Wagner D; Reddy KR; Mathebula F; Tolley EE; Baeten JM; Palanee-Phillips T; Montgomery ET
    AIDS Behav; 2023 Jun; 27(6):2030-2040. PubMed ID: 36459264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Montgomery E; Hartmann M; Magazi B; Mathebula F; Schwartz K; Laborde N; Soto-Torres L
    PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and acceptability of pre-exposure prophylaxis use among women in violent relationships.
    Braksmajer A; Leblanc NM; El-Bassel N; Urban MA; McMahon JM
    AIDS Care; 2019 Apr; 31(4):475-480. PubMed ID: 30045629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women's PrEP use.
    Hartmann M; Roberts ST; Triplett N; Tenza S; Maboa O; Mampuru L; Mayisela N; Mbewe D; Tolley EE; Reddy K; Palanee-Phillips T; Montgomery ET
    PLOS Digit Health; 2023 Aug; 2(8):e0000329. PubMed ID: 37578954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff Perceptions of Preimplementation Barriers and Facilitators to a Mobile Health Antiretroviral Therapy Adherence Counseling Intervention in South Africa: Qualitative Study.
    McCreesh-Toselli S; Torline J; Gouse H; Robbins RN; Mellins CA; Remien RH; Rowe J; Peton N; Rabie S; Joska JA
    JMIR Mhealth Uhealth; 2021 Apr; 9(4):e23280. PubMed ID: 33821806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.